Licarbazepine-d4-1

Licarbazepine-d4-1

• CAS Number: 1188265-49-7
• UNSPSC Description: Licarbazepine-d4-1 is deuterium labeled Licarbazepine. Licarbazepine (BIA 2-005; GP 47779) is a voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects[1].
• Target Antigen: Isotope-Labeled Compounds; Sodium Channel
• Type: Isotope-Labeled Compounds
• Related Pathways: Membrane Transporter/Ion Channel;Others
• Applications: Neuroscience-Neuromodulation
• Field of Research: Neurological Disease
• Solubility: 10 mM in DMSO
• Smiles: NC(N1C2=C([2H])C([2H])=C([2H])C([2H])=C2C(CC3=CC=CC=C31)O)=O
• Molecular Weight: 258.31
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Rajinder P Singh, et al. A review of eslicarbazepine acetate for the adjunctive treatment of partial-onset epilepsy. J Cent Nerv Syst Dis. 2011 Jul 20;3:179-87.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported